A Phase II Study of Ro09-1978 and L-OHP in patients with resected gastric cancer
Phase 2
- Conditions
- Stage II, III, gastric cancer patient after curative resection
- Registration Number
- JPRN-jRCT2080221830
- Lead Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Histologically confirmed stage II or III gastric cancer after D2 lymph node dissection by a standard procedure with a diagnosis of R0.
Exclusion Criteria
Lack of complete recovery from the effects of major surgery, History of treatment other than surgery for the underlying disease, Serious hypersensitivity to fluoropyrimidine or platinum compounds, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tolerability
- Secondary Outcome Measures
Name Time Method Efficacy, Safety